A primary goal of medical therapy in cases of glaucoma is to reduce intraocular pressure. The once-daily prostaglandin analogues provide great reductions in IOP and are commonly used first-line treatment for patients with glaucoma and ocular hypertension. In order to achieve a target level of IOP, use of the single drug is preferred over the use of multiple IOP lowering drugs to ensure effective treatment and minimize the risk of adverse effects.
Difference between Bimatoprost and Latanoprost
The mechanism of action of these medications in lowering IOP is still not understood and is shown to act by increasing aqueous humor (eye fluid) outflow through both the trabecular route and the uveoscleral pathway. Among all the ocular hypotensive medications that are available to employed in the treatment of open-angle glaucoma and ocular hypertension, Bimatoprost and Latanoprost are the most potent medications. They are relatively new ocular hypotensive medications for the treatment of glaucoma patients. Latanoprost is pharmacologically classified as prostaglandin analogue while Bimatoprost is a prostamide.
So many research took place, but the conversation remains the same regarding the mode of action of action and clinical efficacy of both the active ingredients of ophthalmic solutions. Most of the studies that take place to compare the efficacy and safety of Latanoprost and bimatoprost have shown no significant difference in the IOP lowering the ability of these medications. Both the drugs reduce IOP without significantly affecting the aqueous production rate. They increase eye fluid outflow, either by enhancing the pressure sensitive outflow pathway or by increasing the pressure sensitive outflow.
Latanoprost and Bimatoprost
Latanoprost has a strong effect in lowering the intraocular pressure (IOP) in those patients who are suffering from open-angle glaucoma. It decreases the pressure in the eye. It is an effective treatment for the reduction of elevated IOP in patients with open-angle glaucoma and ocular hypertension. The once-daily administration, preferably in the evening is sufficient to obtain an optimal effect. The regular administration prevents further damage to eyesight due to elevated pressure in glaucoma patients.
Both the compounds are prostaglandin analogues that have a side effect of growing lashes. Likewise, Latanoprost also increases length, thickness, and in a number of eyelash strands. Many clinical studies were conducted to show the efficacy of Latanoprost in promoting eyelash growth. It has been revealed that the active compound, when administered inside the eye, increases the number, length, curvature, and pigmentation.
Of all the prostaglandins, Bimatoprost is considered as the best regarding eyelash growth. It effectively increases the density, length and darkness.
The use of both the prostaglandin analogues as an eyelash enhancer is becoming popular. Both are available at premiumrxdrugs.com under the brand name of 9 PM eye drops, Xalatan eye drops (Latanoprost), Bimat, careprost, and Actavis Bimatoprost (Bimatoprost).